S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
Log in
NASDAQ:ESPR

Esperion Therapeutics Options Chain and Prices

$25.12
-0.43 (-1.68 %)
(As of 01/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$24.76
Now: $25.12
$26.19
50-Day Range
$25.55
MA: $28.61
$31.36
52-Week Range
$23.90
Now: $25.12
$76.98
Volume1.21 million shs
Average Volume944,052 shs
Market Capitalization$700.27 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48

Options Chain

Esperion Therapeutics (NASDAQ:ESPR) Options Chain

 $ 
ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades
2/19/2021$45.00$0.000Call0002
(+0)
0.00
2/19/2021$40.00$0.000Call330108
(+0)
0.995588
(+0.19009)
0.01
2/19/2021$35.00$0.175Call980158
(+7)
0.743629
(-0.003065)
0.0775447
2/19/2021$30.00$0.475Call1489334309
(+49)
0.644319
(-0.046873)
0.1973436
2/19/2021$25.00$2.450Call1321125
(+6)
0.82179
(-0.099102)
0.5556969
2/19/2021$22.50$4.100Call61024
(+8)
0.935862
(-0.091728)
0.705582
2/19/2021$20.00$5.150Call1003
(+2)
0.408855
(-0.313142)
0.9757621
2/19/2021$17.50$7.550Call0000
(+0)
0
2/19/2021$15.00$10.050Call0000
(+0)
0
2/19/2021$45.00$20.100Put0000
(+0)
1.19054
(+0.232971)
-0.9352960
2/19/2021$40.00$15.450Put00010
(+2)
1.26184
(+0.460669)
-0.860580
2/19/2021$35.00$11.150Put11022
(+0)
1.33955-0.7436221
2/19/2021$30.00$5.000Put10161
(+4)
0.432312
(-0.099131)
-0.913481
2/19/2021$25.00$1.875Put18515919209
(+28)
0.668278
(+0.08265)
-0.45157730
2/19/2021$22.50$0.900Put124100222117
(+53)
0.695354
(+0.16003)
-0.25952619
2/19/2021$20.00$0.350Put49319159
(+104)
0.737065
(+0.022964)
-0.1188899
2/19/2021$17.50$0.150Put00010
(+0)
0.842038-0.0524160
2/19/2021$15.00$0.000Put0000
(+0)
0.00
End-of-day options data provided by Trade Alert and Intrinio.

This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.